Loredana Nicoletti

Dr. Loredana Nicoletti

National Reference Laboratory for Measles and Rubella, Department of Infectious Diseases, Italian National Institute of Health, Rome 00161, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2010 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
FCFilippo Curtale
Filippo Curtale
FPFabrizio Perrelli
Fabrizio Perrelli
JMJessica Mantovani
Jessica Mantovani
MAMarta Ciofi degli Atti
Marta Ciofi degli Atti
Antonietta FiliaAntonietta Filia
Antonietta Filia
DLDomenico Di Lallo
Domenico Di Lallo
Despite the launch of the national plan for measles elimination, in Italy, immunization coverage remains suboptimal and outbreaks continue to occur. Two measles outbreaks, occurred in Lazio region during 2006-2007, were investigated to identify sources of infection, transmission routes, and assess operational implications for elimination of the disease.

1 February 2021 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
FMFabio Magurano
Fabio Magurano
MBMELISSA BAGGIERI
MELISSA BAGGIERI
AMAntonella Marchi
Antonella Marchi
GRGiovanni Rezza
Giovanni Rezza
LNLoredana Nicoletti
Loredana Nicoletti
SGSilvia Gioacchini
Silvia Gioacchini
The goal of the current study is to evaluate whether the increase of temperature can influence the environmental endurance of SARS-CoV-2. The virus was inoculated on plastic surface and harvested at predefined time-points in parallel at 20-25°C (RT) and at 28°C (JT). Samples collections were tested by TCID50 titers on Vero cells. Samples collections were tested by TCID50 titers on Vero cells. Our results confirm that fomite transmission of the emerging SARS-CoV2 is possible: the virus reserved its ability to infect cells up to 84 hours at both RT and JT on plastic surface, with a TCID50 viral titre of 0,67 and 0,25 log10 respectively. At RT, an important reduction in the viral titre, from 4 log10 to 3 log10 TCID50 was observed during the first 24-36 hours. At JT the same decay was observed more rapidly (between 8 and 12 hours), The rate of viral inactivation by D-value was 24.74 at RT and 12,21 hours at JT. This remarkable difference between the two temperatures suggests that virus vitality can be influenced by the environmental temperature and that the hot season could reduce the probability of COVID-19 transmission.

22 November 2013 in Viruses
Verified
Journal Article
Open access
PDF file
Luisa BarzonLuisa Barzon
Luisa Barzon
MPMonia Pacenti
Monia Pacenti
EFElisa Franchin
Elisa Franchin
SPSilvana Pagni
Silvana Pagni
Enrico LavezzoEnrico Lavezzo
Enrico Lavezzo
Giorgio  PalùGiorgio Palù
Giorgio Palù
Human cases of West Nile virus (WNV) disease have been reported in Italy since 2008. So far, most cases have been identified in north-eastern Italy, where, in 2012, the largest outbreak of WNV infection ever recorded in Italy occurred. Most cases of the 2012 outbreak were identified in the Veneto region, where a special surveillance plan for West Nile fever was in place. In this outbreak, 25 cases of West Nile neuroinvasive disease and 17 cases of fever were confirmed. In addition, 14 WNV RNA-positive blood donors were identified by screening of blood and organ donations and two cases of asymptomatic infection were diagnosed by active surveillance of subjects at risk of WNV exposure. Two cases of death due to WNND were reported. Molecular testing demonstrated the presence of WNV lineage 1 in all WNV RNA-positive patients and, in 15 cases, infection by the novel Livenza strain was ascertained. Surveillance in other Italian regions notified one case of neuroinvasive disease in the south of Italy and two cases in Sardinia. Integrated surveillance for WNV infection remains a public health priority in Italy and vector control activities have been strengthened in areas of WNV circulation.

1 February 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
FMFabio Magurano
Fabio Magurano
MBMELISSA BAGGIERI
MELISSA BAGGIERI
FMFrancesca Mazzilli
Francesca Mazzilli
PBPaola Bucci
Paola Bucci
AMAntonella Marchi
Antonella Marchi
LNLoredana Nicoletti
Loredana Nicoletti
In 2017, Italy experienced one of the largest outbreaks of measles in recent years, with 5404 notified cases and 4347 confirmed cases. A further 2029 cases were notified during the first 6 months of 2018, and 1516 of them were laboratory-confirmed. The B3 and D8 genotypes were identified as those responsible for the outbreak. Possible transmission routes can be established by monitoring the circulating measles virus strains in support of the national health authorities to warn people and travellers.

Christian NapoliChristian Napoli
Christian Napoli
ABAntonino Bella
Antonino Bella
SDSilvia Declich
Silvia Declich
GGGiuliano Grazzini
Giuliano Grazzini
LLLetizia Lombardini
Letizia Lombardini
CRCaterina Rizzo
Caterina Rizzo
In Italy, a West Nile virus (WNV) surveillance plan was firstly implemented in 2008 and 2009 in two affected regions and, since 2010, according to a national plan, a WNV neuroinvasive disease (WNND) surveillance has to be carried out each year during the period 15 June–30 November, in those regions where WNV circulation has been demonstrated among humans, animals or vectors. Moreover, since WNV can be transmitted to humans even by blood transfusions and organ transplants obtained from infected donors, the national surveillance integrates the blood transfusions and organs transplant surveillances too. The paper describes the results of this integrated human surveillance in Italy in 2012. Overall, in 2012, 28 autochthonous confirmed cases of WNND were reported, 14 blood donations were found WNV positive by Nucleic Acid Amplification Test and no solid organ donors tested positive for WNV. Moreover, 17 cases of WNV fever were confirmed in Veneto region. When comparing the number of WNND cases reported to the surveillance system in previous 4 years (43 cases during the period 2008–2011), with those reported in 2012 an important increase was observed in 2012. The geographic distribution of human cases was consistent with the WNV circulation among animals and vectors. Moreover, the implementation of preventive measures for WNV transmission through blood components allowed the detection of blood donors positive for WNV, avoiding the further spread of the disease. Since surveillance strategies and preventive measures are based on the integration among human, animal and vector control activities, the Italian experience could be considered a good example of collaboration among different sectors of public health in a “one health” perspective.

1 March 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
FMFabio Magurano
Fabio Magurano
MBMELISSA BAGGIERI
MELISSA BAGGIERI
CFClaudia Fortuna
Claudia Fortuna
ABAntonino Bella
Antonino Bella
Antonietta FiliaAntonietta Filia
Antonietta Filia
LNLoredana Nicoletti
Loredana Nicoletti